Vertex Pharmaceuticals (VRTX) Form 144 Filed on June 18

AI Summary

Vertex Pharmaceuticals Inc. (VRTX) filed Form 144 on June 18, which allows for the sale of restricted securities. The form indicates that there may be upcoming stock sales by the company's affiliates. Such filings are essential as they provide transparency regarding insider trading activities and can impact investor sentiment. Understanding the details of these transactions can help investors gauge market movements and the potential supply of shares.